FitLife Brands files SEC reports that document results and Regulation FD communications for its nutritional supplement and wellness products business. Recent 8-Ks include earnings releases, call transcripts, corporate presentation materials, and financial results discussions that separate online and wholesale sales activity and incorporate Irwin Naturals after the completed asset acquisition.
Other filings record material definitive agreements, including the credit agreement used in connection with the Irwin Naturals asset purchase and debt refinancing, along with stockholder-meeting results covering director elections, executive-compensation advisory votes, vote-frequency determinations, and auditor ratification.
FitLife Brands reported strong top-line growth for the quarter ended March 31, 2026, with revenue rising to $25.3 million, up 59% from $15.9 million a year earlier, largely driven by the acquisition of Irwin Naturals. Legacy FitLife revenue declined 22% to $12.5 million as both online and wholesale sales softened, particularly at MRC and GNC.
Gross profit increased to $9.5 million, but gross margin fell to 37.6% from 43.1% as Irwin operates at lower margins. Net income decreased 15% to $1.7 million, or $0.18 basic EPS, reflecting higher SG&A and interest expense from the expanded business and debt structure. Adjusted EBITDA was essentially flat at $3.3 million.
The company ended the quarter with $104.3 million in total assets, including $51.2 million of intangibles and $19.4 million of goodwill, and total liabilities of $58.9 million. FitLife carried $37.6 million on its Irwin term loan and $4.2 million on its revolving credit line, while maintaining positive working capital of $10.8 million and generating $2.5 million of operating cash flow.
FitLife Brands, Inc. filed Amendment No. 1 to its annual report for the year ended December 31, 2025 to update Part III disclosures on directors, executive compensation, ownership, related parties and auditor matters.
The filing details a largely independent board and three standing committees, outlines at‑will arrangements and option grants for senior executives, and reports that CEO Dayton Judd beneficially owns 5,831,058 shares, or 58.7% of the common stock as of April 21, 2026. It also shows non‑affiliate equity market value of $50.75 million, continued use of Weinberg & Company as auditor, and higher 2025 audit fees versus 2024.
FITLIFE BRANDS, INC. director Seth Yakatan reported an open-market purchase of common stock. He bought 164 shares at a weighted average price of $15.3601 per share, increasing his direct holdings to 593 shares of FITLIFE BRANDS common stock.
The purchase was executed under a pre-arranged Rule 10b5-1 trading plan, and occurred through multiple trades within a price range of $15.29 to $15.75 per share.
FITLIFE BRANDS, INC. director Matthew Lingenbrink made an open-market purchase of the company’s common stock. On April 10, 2026, he bought 3,000 shares at $9.76 per share, increasing his direct holdings to 8,800 shares. According to a footnote, the purchase followed Board approval to temporarily extend the trading window under the company’s Insider Trading Policy after disclosure of the expected range of operating results for the quarter ending March 31, 2026 and confirmation that there was no undisclosed material information.
FITLIFE BRANDS, INC. director Grant Robert Dawson made an open-market purchase of 3,000 shares of Common Stock at $9.98 per share, increasing his direct holdings to 158,000 shares. The shares were bought after the Board approved a temporary extension of the trading window under the company’s Insider Trading Policy, following disclosure of the expected range of operating results for the quarter ending March 31, 2026 and confirmation that there was no undisclosed material information.
FitLife Brands discussed fourth-quarter and full-year 2025 results, emphasizing the first full quarter of owning Irwin Naturals. Q4 2025 revenue was $25.9 million, up 73% year over year, driven mainly by Irwin, while Legacy FitLife brands saw revenue declines amid softer consumer demand.
Wholesale Q4 revenue reached $15.5 million (up 213%), online revenue was $10.5 million (up 4%), and adjusted gross margin was 37.0% versus 41.4% a year ago due to Irwin’s lower historical margins. Net income was $1.6 million versus $2.1 million, while adjusted EBITDA rose 14% to $3.5 million. Management highlighted Irwin’s Q4 revenue of $12.6 million and fast-growing Amazon channel, now at roughly $0.8 million in monthly revenue. The company reduced term debt by $1.9 million to $44.7 million and outlined initiatives to improve Irwin’s supply chain, extend product shelf life, grow off-Amazon awareness, cross-sell brands through Irwin’s sales team, and trim SG&A, while noting ongoing macro and Amazon-related headwinds and choosing not to give 2026 guidance.
FitLife Brands reported strong 2025 revenue growth but weaker profitability. Full-year revenue rose to $81.5M from $64.5M, helped by the Irwin acquisition, while net income fell to $6.3M from $9.0M as margins and expenses pressured earnings.
Gross margin declined to 38.6% from 43.6%, and adjusted EBITDA was roughly flat at $14.0M. In Q4 2025, revenue grew 73% to $25.9M, but gross margin slipped to 34.5%. The company ended 2025 with a term loan of $39.1M, revolver borrowings of $5.6M, and cash of $1.6M, and is prioritizing debt reduction.
Management highlighted persistent demand weakness across most brands in early 2026, but noted rapid online growth for Irwin, particularly on Amazon, where annualized revenue has reached an estimated $9–10M run rate.
FitLife Brands, Inc. filed its annual report describing a year of significant expansion driven by acquisitions and e‑commerce growth. The company bought substantially all assets of Irwin Naturals for $42.5 million, funded by a $29.75 million term loan, $6.0 million from a new $10.0 million revolver, and cash.
FitLife executed a 2‑for‑1 stock split on February 7, 2025, and ended the year with 9,391,072 common shares outstanding and non‑affiliate equity valued at $50.75 million. About 49% of 2025 sales came from Amazon’s U.S. marketplace and 14% from GNC’s centralized distribution, underscoring heavy channel concentration.
Total debt reached $44.7 million, mainly from deal financing, while headcount more than doubled to 81 employees, reflecting integration of acquired brands. The report highlights intense competition, regulatory exposure in nutrition and supplements, customer concentration risks, rising leverage, and cybersecurity oversight but notes no material legal proceedings or identified material cybersecurity incidents.
FitLife Brands furnished an 8-K announcing it issued a press release with financial results for the quarter ended September 30, 2025. The press release is furnished under Items 2.02 and 7.01 as Exhibit 99.1 and, as stated, is not deemed “filed” under Section 18 and is not incorporated by reference unless specifically identified. The company’s common stock trades on the Nasdaq Capital Market under the symbol FTLF.
FitLife Brands reported third-quarter results and detailed its August acquisition of Irwin Naturals. Q3 revenue was $23,485, up 47% year over year, driven by the Irwin addition and growth at MusclePharm. Net income was $921 with diluted EPS of $0.09.
Gross margin declined to 37.2% from 43.8%, reflecting Irwin’s historically lower margins and a $392 inventory step-up amortization. Operating expenses rose on transaction costs ($820 in Q3). For the nine months, revenue reached $55,548 and net income was $4,686.
FitLife closed the Irwin deal for approximately $42,500, funded by a new $40,625 term loan and $6,000 drawn on a $10,000 revolver, both with SOFR-based rates. Covenants begin with the quarter ending Dec 31, 2025. To manage rate risk, the company entered a swap on Sep 5, 2025 fixing $20,000 notional at 3.39% to Aug 8, 2030. Shares outstanding were 9,391,072 as of Nov 12, 2025.